NCT03133741View on ClinicalTrials.gov

Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

July 1, 2017

Study Completion Date

July 1, 2017

Conditions
Glucose Metabolism Disorders
Interventions
OTHER

GIP-A

GIP-A (GIP receptor antagonist)

OTHER

GLP-1 receptor antagonist Exendin[9-39]

Exendin\[9-39\]

OTHER

Placebo

Saline (9mg/mL)

OTHER

GIP-A + Exendin[9-39]

GIP receptor antagonist + GLP-1 receptor antagonist

Trial Locations (1)

2900

Center for Diabetes Research, Gentofte Municipality

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT03133741 - Inhibition of the Endogenous GIP Response With a GIP Receptor Antagonist | Biotech Hunter | Biotech Hunter